Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ruxolitinib 15mg tablets
0801050BIAAABAB
|
Ruxolitinib | Ruxolitinib | Malignant Disease and Immunosuppression | 2 |
|
Skilarence 30mg gastro-resistant tablets
0802040AKBCAAAC
|
Skilarence | Dimethyl fumar | Malignant Disease and Immunosuppression | 2 |
|
Tacrolimus 2mg modified-release capsules
0802020T0AABJBJ
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 2 |
|
Teriflunomide 14mg tablets
0802040ALAAAAAA
|
Teriflunomide | Teriflunomide | Malignant Disease and Immunosuppression | 2 |
|
Afinitor 10mg tablets
0801050AXBBABAB
|
Afinitor | Everolimus | Malignant Disease and Immunosuppression | 1 |
|
Apalutamide 240mg tablets
0803042V0AAABAB
|
Apalutamide | Apalutamide | Malignant Disease and Immunosuppression | 1 |
|
Azathioprine 200mg/5ml oral liquid
0802010G0AABIBI
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 1 |
|
Bexarotene 75mg capsules
0801050ABAAAAAA
|
Bexarotene | Bexarotene | Malignant Disease and Immunosuppression | 1 |
|
Brabio 40mg/1ml solution for injection pre-filled syringes
0802040U0BCABAC
|
Brabio | Glatiramer acetate | Malignant Disease and Immunosuppression | 1 |
|
Capecitabine 150mg tablets
0801030V0AAABAB
|
Capecitabine | Capecitabine | Malignant Disease and Immunosuppression | 1 |
|
Chlorambucil 2mg tablets
0801010F0AAAAAA
|
Chlorambucil | Chlorambucil | Malignant Disease and Immunosuppression | 1 |
|
Cyprostat 100mg tablets
0803042E0BBABAB
|
Cyprostat | Cyproterone acetate | Malignant Disease and Immunosuppression | 1 |
|
Dailiport 5mg modified-release capsules
0802020T0BKADAP
|
Dailiport | Tacrolimus | Malignant Disease and Immunosuppression | 1 |
|
Everolimus 250microgram tablets
0801050AXAAADAD
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | 1 |
|
Everolimus 750microgram tablets
0801050AXAAAEAE
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | 1 |
|
Fareston 60mg tablets
0803041U0BBAAAA
|
Fareston | Toremifene citrate | Malignant Disease and Immunosuppression | 1 |
|
Firmagon 120mg inj vials
0803042R0BBABAB
|
Firmagon | Degarelix | Malignant Disease and Immunosuppression | 1 |
|
Jakavi 20mg tablets
0801050BIBBACAC
|
Jakavi | Ruxolitinib | Malignant Disease and Immunosuppression | 1 |
|
Lenalidomide 25mg capsules
0802040Y0AAADAD
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | 1 |
|
Methotrexate 1g/10ml solution for injection vials
0801030P0AACKCK
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 1 |
|
Methotrexate 50mg/2ml solution for injection vials
0801030P0AAANAN
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 1 |
|
Nilotinib 200mg capsules
0801050ASAAAAAA
|
Nilotinib | Nilotinib | Malignant Disease and Immunosuppression | 1 |
|
Nolvadex D 20mg tablets
0803041S0BCABAB
|
Nolvadex | Tamoxifen citrate | Malignant Disease and Immunosuppression | 1 |
|
Ofev 150mg capsules
0801050BTBCABAB
|
Ofev | Nintedanib | Malignant Disease and Immunosuppression | 1 |
|
Osimertinib 80mg tablets
0801050CGAAABAB
|
Osimertinib | Osimertinib | Malignant Disease and Immunosuppression | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.